Progression of immune checkpoint in breast cancer
JING Jing
ZHANG Minghui
Abstract:Immune checkpoint plays an important role in maintaining self-tolerance and preventing immune system from attacking normal tissues.Tumor cells take advantage of these mechanisms to evade immune recognition.At present,the most important immune checkpoints are cytotoxic T-lymphocyte antigen-4(CTLA4),programmed death-1 (PD-1) and programmed death ligand-1 (PD-L1).PD-L1 binds PD-1 to reduce the cellular immune response by inducing T-cell apoptosis or exhaustion.Immune checkpoint blockade improves the survival of patients with cancer.Despite the limited understanding,checkpoint blockade as a novel therapeutic approach may change the treatment paradigm of breast cancer in the future.In this paper,recent advances of immune checkpoint blockade in breast cancer are reviewed.
Keywords:Breast cancerImmune checkpointImmune checkpoint blockade
Publication Date:2017-01-01
Online Publishing Date:2025-08-15(First online date of this platform, not the publication date of the document)
Pages:4( 748-751 )
